Regenicin Inc
OTC:RGIN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Regenicin Inc
OTC:RGIN
|
US |
|
I
|
ID Logistics SAS
F:1ID
|
FR |
|
S
|
SandRidge Energy Inc
F:SA2D
|
US |
|
Oracle Financial Services Software Ltd
NSE:OFSS
|
IN |
|
Fomento de Construcciones y Contratas SA
F:FCC
|
ES |
|
A
|
APTIV PLC
SWB:D7A
|
CH |
|
F
|
Fluor Corp
XMUN:FLU
|
US |
|
Atossa Therapeutics Inc
NASDAQ:ATOS
|
US |
|
Mersen SA
F:CBE
|
FR |
|
S
|
Sumitomo Metal Mining Co Ltd
DUS:S19
|
JP |
|
Parrot SA
F:P2W
|
FR |
|
Pointerra Ltd
OTC:PTRRF
|
AU |
|
Universal Music Group NV
F:0VD
|
NL |
|
G
|
Gibraltar Industries Inc
XMUN:GI2
|
US |
|
P
|
PPL Corp
DUS:PP9
|
US |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Regenicin Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Regenicin Does
Regenicin, Inc. is a biotechnology company, which specializes in the development of regenerative cell therapies to restore the health of damaged tissues and organs. The company is headquartered in Las Vegas, Nevada and currently employs 3 full-time employees. The company went IPO on 2008-05-12. The firm is focused on developing and commercializing a lifesaving technology through the introduction of tissue-engineered skin substitutes to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a range of plastic surgery procedures.
- Headquarters
- United States of America US
- Employees
- 3
- IPO date
- May 12, 2008